Introduction
3-Aminobenzanthrone (3-ABA, Fig. 1 ) is the reduced metabolite of the carcinogenic environmental pollutant, the nitroketone 3-nitrobenzanthrone (3-nitro-7H-benz [de] anthracen-7-one, 3-NBA, Fig. 1 ) [1, 2] . In recent years 3-NBA has received much attention due to its presence in diesel exhaust and its extremely high mutagenic potency in the Salmonella Ames assay [3] [4] [5] . 3-NBA is carcinogenic in rats, causing lung tumours after intratracheal instillation, and it is also a suspected human carcinogen [4] [5] [6] . The uptake of 3-NBA in humans has been demonstrated by the detection of its metabolite 3-ABA in urine samples of salt mine workers occupationally exposed to diesel emissions [4] . 3-ABA was also the main metabolite of 3-NBA formed in human fetal bronchial cells and rat lung alveolar type II cells [7] . In addition, 3-ABA was found suitable for dyeing microporous polyethylene films, which are widely used for practical purposes such as separation of liquid mixtures, in particular, as separation membranes in chemical batteries [8] , or to fluorescently label phospholipid membranes in the form of its N-palmitoyl derivative [9] . This suggests its industrial and/or laboratory utilization, leading to a putative exposure of people. This is a matter of concern, because we have demonstrated the genotoxicity of both 3-NBA and 3-ABA by the detection of specific DNA adducts formed in vitro and in vivo [10] [11] [12] [13] [14] [15] [16] [17] . The predominant DNA adducts formed from 3-NBA and 3-ABA are 2-(2'-deoxyguanosin-N Recently we have demonstrated the role of rat hepatic, pulmonary and renal NAD(P)H:quinone oxidoreductase (NQO1) in reducing 3-NBA to species that are further activated by N,Oacetyltransferases (NATs) and sulfotransferases (SULTs) to form DNA adducts [13, 20, 21] . These enzymes are also the major activation enzymes for 3-NBA in human liver [13] . Cytochromes P450
(CYP) 1A1 and 1A2 are essential for the oxidative activation of 3-ABA in human and rat livers, leading to the same DNA adducts that are formed in vivo by 3-ABA or 3-NBA [12] . CYP1A1 is also an efficient activator of 3-ABA in microsomal fractions from rat kidneys and lungs, while and myeloperoxidase (MPO) were found to be effective in activating 3-ABA [14] (Fig. 1) .
We have already shown that both 3-ABA and 3-NBA induce the major enzymes activating both toxins in rat livers (NQO1, CYP1A) [20] , and that 3-NBA is also a potent inducer of these enzymes in rat lungs and kidneys [21] . Since lung is the major target of 3-NBA and its major metabolite 3-ABA is excreted in urine, it was important to see if 3-ABA like 3-NBA induces the activating enzymes in these two organs.
Material and Methods

Chemicals
NADPH, deoxyadenosine 3'-monophospate, deoxyguanosine 3'-monophosphate, acetyl coenzyme A (acetyl-CoA), 3'-phosphoadenosine-5'-phosphosulfate (PAPS), menadione (2-methyl-1,4-naphthoquinone) and calf thymus DNA were from Sigma Chemical Co (St Louis, MO, USA);
Sudan I from BDH (Poole, UK); 7-ethoxyresorufin from Fluka Chemie AG (Buchs, Switzerland).
Enzymes and chemicals for the 32 P-postlabelling assay were obtained from sources described [22] .
All these and other chemicals were reagent grade or better.
Synthesis of 3-NBA and 3-ABA
3-NBA and 3-ABA were synthesized as described [23] and their authenticity was confirmed by UV spectroscopy, electrospray mass spectrometry and high field proton NMR spectroscopy.
Animal experiments
The study was conducted in accordance with the Regulations for the Care and Use of Laboratory Animals (311/1997, Ministry of Agriculture, Czech Republic), which is in compliance with Declaration of Helsinki. Male Wistar rats (100-125 g, n=3 per group) were treated with a single i.p. dose of 0.4, 4 or 40 mg/kg bw of 3-ABA (dissolved in sunflower oil at a concentration of 0.4 or 4 mg/ml). Three control animals received an equal volume of sunflower oil only. Rats were placed in cages in temperature and humidity controlled rooms. Standardised diet and water were provided ad libitum. The animals were killed 24 hours after treatment by cervical dislocation. Lungs and kidneys were removed immediately after death and used for isolation of mRNA and for preparation of microsomal and cytosolic fractions.
Preparation of microsomal and cytosolic fractions
Microsomal and cytosolic fractions were isolated from the lungs and kidneys of rats, either uninduced or pretreated with 3-ABA (see above) as described [24,25].
Cytosolic incubations
The deaerated and argon-purged incubation mixtures, in a final volume of 750 µl, consisted of 50 mM Tris-HCl buffer (pH 7.4), containing 0.2% Tween 20, cofactors for cytosolic enzymes (1 mM NADPH, 2 mM acetyl-CoA; 100 µM PAPS), pooled lung and kidney cytosolic sample from 3 rats, treated either with vehicle (control) or with 40 mg/kg bw of 3-ABA (1 mg of cytosolic protein), 30 µM 3-NBA (dissolved in 7.5 µl dimethylsulfoxide) and 0.5 mg of calf thymus DNA (2 mM dNp). The reaction was initiated by adding 3-NBA. Incubations with rat cytosols were carried out at 37°C for 3 hr; the cytosol-mediated 3-NBA-derived DNA adduct formation was found to be linear up to 4 hr [13] . Control incubations were carried out either (i) without activating system (cytosol), (ii) without cofactors (NADPH, acetyl-CoA, PAPS), (iii) without DNA or (iv) without 3-NBA. After extraction with ethyl acetate, DNA was isolated from the residual water phase by the phenol/chloroform extraction method as described [13] .
Incubations used to evaluate the activation of 3-ABA by peroxidases in rat pulmonary and renal 
Microsomal incubations
Incubation mixtures, in a final volume of 750 µl, consisted of 50 mM potassium phosphate buffer (pH 7.4), 1 mM NADPH or 0.1 mM arachidonic acid, pooled pulmonary and renal microsomal fractions from 3 rats, either control or treated with 40 mg/kg bw of 3-ABA (0.5 mg of microsomal protein), 100 µM 3-ABA or 3-NBA (dissolved in 7.5 µl dimethylsulfoxide) and 0.5 mg of calf thymus DNA. The reaction was initiated by adding 3-ABA or 3-NBA and were carried out at 37°C for 2 hr; microsomal-mediated 3-NBA (3-ABA)-derived DNA adduct formation was found to be linear up to 3 hr [12, 26] . Control incubations were carried out either (i) without activating system (microsomes), (ii) with activating system and 3-ABA, but without DNA or (iii) with activating system and DNA but without 3-ABA. After the incubation and extraction with ethyl acetate, DNA was isolated from the residual water phase by the phenol/chloroform extraction method as described [12] . P-Postlabelling analysis using butanol extraction, thin layer chromatography (TLC) and HPLC was performed as described [15] . Enrichment by butanol extraction has been shown to yield more adduct spots and a better recovery of 3-NBA (3-ABA)-derived DNA adducts than using enrichment by nuclease P1 digestion [10, 12] . DNA adduct spots were numbered as reported previously [15] . As reference compounds dAp and dGp (4 µmol/ml) (Sigma) were incubated with 3-NBA (300 µM) activated by xanthine oxidase (1 U/ml) (Sigma) in the presence of hypoxanthine and analysed as described previously [10] . DNA adduct standard samples of 3-NBA, 2-(2'- 
Preparation of antibodies
Leghorn chicken were immunised subcutaneously three times a week with rat recombinant CYP1A1 and human recombinant NQO1 (Sigma) antigens (0.1 mg/animal) emulsified in complete Freund's adjuvant for the first injection and in incomplete adjuvant for boosters.
Immunoglobulin fraction was purified from pooled egg yolks using fractionation by polyethylene glycol 6000 [27]. 
CYP1A1 and NQO1 enzyme activity assays
The microsomal samples were characterised for CYP1A1 activity using 7-ethoxyresorufin Odeethylation (EROD) activity and the oxidation of Sudan I [27,28]. The cytosolic samples were characterised for NQO1 activity, using menadione (2-methyl-1,4-naphthoquinone) as a substrate [24, 25] . NQO1 activity was determined by following the oxidation of NADPH spectrophotometrically at 340 nm. The standard assay system contained 25 mM Tris-HCl (pH 7.4), 0.2% Tween 20, 0.07% bovine serum albumin, 400 mM NADPH and 100 mM menadione dissolved in methanol.
CYP1A1 and NQO1 mRNA content in rat lungs and kidneys
Total RNA was isolated from frozen lungs and kidneys of three untreated rats and three rats pretreated with 40 mg/kg body weight of 3-ABA using Trizol Reagent (Invitrogen, Carlsbad, CA, USA) according to the procedure supplied by the manufacturer. The quality of isolated RNA was verified by horizontal agarose gel electrophoresis, and RNA quantity was assessed by UV-VIS spectrophotometry on a Carry 300 spectrophotometer (Varian, Palo Alto, CA, USA). RNA samples 
.
Results
The effect of 3-ABA pretreatment on the expression of enzymes activating 3-NBA and 3-ABA
Because CYP1A1 and NQO1 are the essential enzymes activating 3-ABA and 3-NBA in rat lungs and kidneys [24] and in rat and human livers [12, 13] , we evaluated whether treating rats with 3-ABA influences their expression. Induction of these enzymes has already been found in the livers of rats treated with 3-ABA or the parent nitroketone, 3-NBA [20] . Western blots with chicken polyclonal antibodies raised against rat CYP1A1 showed that the expression of this enzyme was also induced in rat lung and kidney by 3-ABA ( Fig. 2) , whereby the induction of protein expression was higher in kidney than in lung (3.4-fold versus 2.5-fold at 40 mg/kg bw). EROD activity and oxidation of Sudan I, markers of CYP1A1 activity [27,28], were higher in both organs of rats treated with 3-ABA (Table 1) . Again, the induction in kidney was higher than in lung (up to 4.8-fold versus 2.5-fold at 40 mg/kg bw), although control enzyme activity in lung was only half of that in kidney.
In contrast to CYP1A1, the levels of renal NQO1 protein were not increased by pretreating rats with 3-ABA; on the contrary lower expression levels were found in kidney cytosolic fractions of rats treated with 4 and 40 mg/kg bw of 3-ABA (Fig. 2) . In the case of lung, NQO1 protein expression was increased 1.4-fold in rats treated with 40 mg/kg bw of 3-ABA. The increase in NQO1 activities in pulmonary cytosol depended on the administered dose and correlated with protein expression (Table 2 and Fig. 2 ). Up to a 1.6-fold increase in NQO1 activity measured with menadione as a substrate was found in lung of rats treated with 3-ABA ( Table 2) .
Besides the evaluation of the effects of 3-ABA on protein levels and enzyme activities of CYP1A1 and NQO1, changes in mRNA expression levels by the compound were also investigated.
The relative amounts of CYP1A1 and NQO1 mRNA were measured by RT-PCR. As shown in Table 3 , treatment of rats with 40 mg/kg bw of 3-ABA increased mRNA levels of CYP1A1 and NQO1 in the lung and NQO1 in the kidney.
The effect of 3-ABA pretreatment on activation of 3-NBA by rat pulmonary and renal cytosolic and microsomal fractions
Since NQO1 and CYP1A1, the enzymes relevant for 3-NBA and 3-ABA activation [12, 13, 20, 21] were induced by 3-ABA, we investigated whether 3-ABA treatment increased the bioactivation of 3-ABA and 3-NBA by microsomal and cytosolic fractions. DNA adduct formation by 3-ABA and 3-NBA was measured by TLC 32 P-postlabelling.
Cytosolic samples from both organs were capable of reductively activating 3-NBA to species forming DNA adducts (see Fig. 3A for the renal cytosol). The DNA adduct pattern generated by 3-NBA consisted of a cluster of up to five adducts (spots 1−5 in Figure 3 ) essentially identical to that observed in vivo in rats and mice treated with 3-NBA [10, 11, 13, 16, 17] , and in in-vitro incubations using human and rat hepatic cytosols [13] or microsomes [26] . TLC autoradiograms of Pulmonary cytosolic samples from rats pretreated with 3-ABA (40 mg/kg bw) were more effective in the formation of 3-NBA-DNA adducts in the presence of NADPH, the cofactor of NQO1, than the pulmonary cytosol from untreated (control) rats (Fig. 4 and Supporting Table S1 ).
The formation of 3-NBA-DNA adducts was 1.5-fold higher in incubations with cytosols of rats treated with 3-ABA relative to those of control rats. Addition of PAPS or acetyl-CoA, cofactors of SULTs and NATs, respectively, which enhance 3-NBA activation [13, 20, 24] , to the incubations with induced cytosols had essentially the same stimulatory effects on 3-NBA adduct formation as in control cytosols. A 2.3-(with PAPS) and 20.3-fold (with acetyl-CoA) increase was observed in comparison to the activity using NADPH alone. In renal cytosols similar effects were elicited by 3-ABA treatment, 3-NBA-DNA adduct levels were 1.2-fold higher than in incubations with cytosols from control kidneys. PAPS addition led to similar increases as in lung cytosolic incubations, but acetyl-CoA was even more effective, leading to ~30-fold higher levels of DNA adducts both in cytosols from 3-ABA treated rats and in those from control rats.
Contrary to the efficient 3-NBA activation by cytosolic reductases and conjugating enzymes, microsomal fractions isolated from either control or 3-ABA treated rat lungs or kidneys did not activate 3-NBA to DNA binding species.
The effect of 3-ABA pretreatment on activation of 3-ABA by rat pulmonary and renal cytosolic and microsomal fraction
In contrast to 3-NBA, 3-ABA was activated by lung and kidney microsomal fractions. CYP1A1
was found to play a major role in DNA adduct formation by 3-ABA in rat lungs and kidneys [21] , because upon addition of NADPH, a cofactor of CYPs, all pulmonary and renal microsomal fractions were capable of oxidizing 3-ABA to form DNA adducts (see Fig. 3B for the renal microsomal fractions and Supporting Table S2 ). Kidney and lung microsomal fractions from rats treated with 3-ABA (40 mg/kg bw) exhibited 4.5-and 2.8-fold higher efficiencies to activate 3-ABA, than microsomal fractions from untreated rats, respectively ( Table S2 ). Autoradiograms of DNA digests from control incubations carried out in parallel either without microsomal fractions, without NADPH, without arachidonic acid, without DNA, or without 3-ABA were all devoid of adduct spots in the region of interest (data not shown).
In the presence of hydrogen peroxide, a cofactor for peroxidases, pulmonary and renal cytosols from control (uninduced) and 3-ABA-treated rats activated 3-ABA to form DNA adducts. In contrast to pulmonary cytosol, by which five 3-ABA-DNA adducts (spots 1-5 in Figure 3) were generated, only four 3-ABA-DNA adducts (spots 1-4 in Figure 3 ) were detected in the renal cytosolic activation system. Treatment of rats with 3-ABA slightly stimulated the formation of 3-ABA-DNA adducts in cytosols from both organs (Fig 6 and Supporting Table S3 ). No adducts were detectable in controls without cytosols, without 3-ABA, or without hydrogen peroxide. receptor [32] , and polycyclic aromatic hydrocarbons present in cigarette smoke [33, 34] . NQO1 is inducible by a variety of agents with different mechanisms of action (see [35] for a review), including tumour promoters and hydrogen peroxide [36] [37] [38] .
Discussion
Expression levels and activities of NQO1 and CYP1A1 are also influenced by other factors, including several drugs, additional environmental chemicals and genetic polymorphisms [33, 39, 40] .
So far two polymorphisms in the human NQO1 gene have been found in the general population, one of which is associated with an increased risk of urothelial tumours [39] and paediatric leukaemia [41] . The polymorphic expression of CYP1A1 has been attributed to altered expression of the Ah receptor, the transcription factor that modulates its regulation, or the Ah receptor nuclear translocator (Arnt) protein, its associated transcription factor [33, 34, 42] . Moreover, the CYP1A1 gene is genetically polymorphic [33, 34] . So far, CYP1A1*2A, CYP1A1*2B and CYP1A1*4 polymorphisms have been found that might be associated with lung, oesophageal or breast cancer risk and with acute myeloid leukaemia [43] [44] [45] [46] . Thus, genetic polymorphisms in CYP1A and NQO1 genes could be important determinants of a possible lung cancer risk from 3-NBA and its metabolite 3-ABA.
In the present study, we have shown that the expression of NQO1 and CYP1A1 proteins and their enzymatic activities was induced by 3-ABA in lungs of rats treated i.p. with a single dose of 0.4, 4 or 40 mg/kg bw of 3-ABA. This induction leads to an increase in enzyme activities and, thus, in the potential of these enzymes to activate 3-NBA in cytosols (by NQO1) and 3-ABA in microsomes (by CYP1A1) to form covalent DNA adducts, thereby enhancing the first step of their own bioactivation. 3-ABA also efficiently induced the expression of CYP1A1, but not NQO1, in the kidney. This is an interesting feature emphasizing the importance of 3-ABA for induction of its own oxidative activation in the kidney, through which it is excreted. The concentration of 3-ABA, which efficiently induced both enzymes in these extrahepatic organs, was very high, 4 and 40 mg/kg bw, and may not be relevant for human exposure levels. It was however a single dose, while humans are chronically exposed to low levels in certain work places in addition to cigarette smoke. Likewise, the potency of these compounds to induce CYP1A1 was up to 6-fold higher compared to 3-ABA.
Induction of NQO1 and CYP1A1 mRNA levels by 3-ABA was lower than induction of proteins and activities of these enzymes. Similar discrepancies between induction of NQO1 and CYP1A mRNA and protein levels by 3-ABA were observed in rat livers [20] and also for other compounds as found by several authors [40, 42, 59, [61] [62] [63] [64] . It has been reported that some inducers might prolong half-lives of mRNAs, while others increase transcription. Moreover, half-lives of mRNAs are usually much shorter than those of proteins [40, 61, 62] . A 24-h-treatment period was used in this study, because it was found to be an appropriate length of time to observe protein induction by several inducers [59, [63] [64] [65] . The increase in CYP1A1 protein levels and enzyme activities reached a maximum at 12-20 h and then remained constant up to 24 h after treatment with a single dose of inducers before slowly dropping to background levels [59, [63] [64] [65] . In contrast, CYP1A1 mRNA reached its highest level as early as 3-5 h [65] [66] [67] [68] [69] .
Recently, we demonstrated that 3-ABA can be activated in vitro by N-oxidation by several peroxidases including MPO, LPO and COX (Fig. 1) . Activation by peroxidase has also been found in vivo, mainly in kidneys and urinary bladders of 3-ABA-treated mice [14] . N-oxidation of 3-ABA finally leads to nitrenium ions that are responsible for the formation of 3-ABA-derived DNA adducts ( Fig. 1 ). Whereas these ions are generated by CYP-mediated reactions via N-OH-3-ABA [12] [13] [14] 19] , peroxidases should catalyze their formation via an imino-derivative [14, [70] [71] [72] [73] . In the present work we found that pulmonary and renal cytosols from rats treated with 3-ABA were more effective in activating 3-ABA to form DNA adducts in the presence of hydrogen peroxide than cytosols from control rats. The necessity for the presence of hydrogen peroxide indicates that 3-ABA activation might be associated with an increase in peroxidase activities in pulmonary and renal cytosols of 3-ABA-treated rats. However, the levels of DNA adducts generated by hydrogen peroxide-mediated 3-ABA activation were 2-fold lower than those by pulmonary and renal microsomes. Collectively, these results suggest that even though peroxidases might be involved in 3-ABA activation in these tissues, they play only a minor role.
3-ABA delivered i.p. is absorbed via the mesenteric veins and lymphatic system, and passes through the liver. Thus, its concentration and effect in this tissue should be higher than in the distal tissues such as lung and kidney. Indeed, the induction of NQO1 and CYP1A1 proteins and enzymatic activities in rat liver after identical i.p. treatment was up to 6-and 2-fold higher than in lungs and kidneys, respectively [20, present paper].
The activation of the parent nitro compound 3-NBA is much more effective by cytosolic reductases than by microsomal enzymes and 3-NBA is a more potent genotoxic compound than its metabolite 3-ABA. This is reflected in the levels of total DNA adducts generated in lung microsomes with NADPH from 3-ABA, which are not higher than those formed from 3-NBA in lung cytosol without added cofactor.
In conclusion, the results of the present study show, for the first time, that 3-ABA is capable of inducing NQO1 and CYP1A1 in lung and CYP1A1 in kidney of rats. These were found to be the predominant biotransforming enzymes involved in the metabolic activation of 3-NBA and 3-ABA, not only in these organs in rats [21] , but also in the liver of both rats and humans [12, 13, 20 
